Abstract
Stroke and neurological outcomes in the early phase following revascularization for moyamoya disease (MMD) may depend on the patient’s age. In this study, an age-stratified comparative analysis was performed to clarify this issue. We reviewed 105 MMD patients who underwent 179 revascularization surgeries. The demographic characteristics were collected in four age groups (≤ 5 and 6–17 years for pediatric patients and 18–49 and ≥ 50 years for adults). Additionally, we assessed the incidence of subsequent stroke and deterioration of modified Rankin Scale (mRS) score. Then, we evaluated predictors of postoperative stroke and mRS deterioration using logistic regression. The mean patient age was 26.2 ± 18.5 years. No significant difference in the incidence of postoperative stroke was observed between age groups; however, the incidence tended to be increased among patients aged ≤ 5 years (17.9%) and patients aged ≥ 50 years (16.7%). Deterioration of mRS scores was significantly associated with ages ≤ 5 years (17.9%) and ≥ 50 years (11.1%). Logistic regression showed that posterior cerebral artery involvement (odds ratio [OR], 4.6) and postoperative transient neurological events (TNEs) (OR, 5.93) were risk factors for postoperative stroke. Age ≤ 5 years (OR, 9.73), postoperative TNEs (OR, 7.38), and postoperative stroke (OR, 49) were identified as predictors of unfavorable neurological outcomes. The novel feature of this comparative analysis by age group is that membership in the early-childhood MMD patient group (under 5 years old) was an independent risk factor for unfavorable short-term neurological outcomes and was mainly associated with the incidence of postoperative severe cerebral infarction.
Similar content being viewed by others
Data availability
The data and materials that support the findings of this study are available from the corresponding author upon reasonable request.
References
Araki Y, Takagi Y, Ueda K, Ubukata S, Ishida J, Funaki T, Kikuchi T, Takahashi JC, Murai T, Miyamoto S (2014) Cognitive function of patients with adult moyamoya disease. J Stroke Cerebrovasc Dis 23:1789–1794. https://doi.org/10.1016/j.jstrokecerebrovasdis.2014.04.032
Araki Y, Uda K, Yokoyama K, Kanamori F, Mamiya T, Nishihori M, Izumi T, Tanahashi K, Sumitomo M, Okamoto S, Wakabayashi T, Natsume A (2020) Surgical designs of revascularization for moyamoya disease: 15 years of experience in a single center. World Neurosurg S1878-8750(1820):30688–30684. https://doi.org/10.1016/j.wneu.2020.03.217
Bao XY, Duan L, Yang WZ, Li DS, Sun WJ, Zhang ZS, Zong R, Han C (2015) Clinical features, surgical treatment, and long-term outcome in pediatric patients with moyamoya disease in China. Cerebrovasc Dis 39:75–81. https://doi.org/10.1159/000369524
Chen Y, Ma L, Lu J, Chen X, Ye X, Zhang D, Zhang Y, Wang R, Zhao Y (2019) Postoperative hemorrhage during the acute phase after direct or combined revascularization for moyamoya disease: risk factors, prognosis, and literature review. J Neurosurg 18:1–10. https://doi.org/10.3171/2019.7.jns19885
Cho WS, Kim JE, Kim CH, Ban SP, Kang HS, Son YJ, Bang JS, Sohn CH, Paeng JC, Oh CW (2014) Long-term outcomes after combined revascularization surgery in adult moyamoya disease. Stroke 45:3025–3031. https://doi.org/10.1161/strokeaha.114.005624
Choi JW, Chong S, Phi JH, Lee JY, Kim HS, Chae JH, Lee J, Kim SK (2020) Postoperative symptomatic cerebral infarction in pediatric moyamoya disease: risk factors and clinical outcome. World Neurosurg 136:e158–e164. https://doi.org/10.1016/j.wneu.2019.12.072
Fujimura M, Kaneta T, Mugikura S, Shimizu H, Tominaga T (2007) Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease. Surg Neurol 67:273–282. https://doi.org/10.1016/j.surneu.2006.07.017
Fujimura M, Shimizu H, Inoue T, Mugikura S, Saito A, Tominaga T (2011) Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranial-intracranial bypass for moyamoya disease: comparative study with non-moyamoya patients using N-isopropyl-p-[(123)I]iodoamphetamine single-photon emission computed tomography. Neurosurgery 68:957–964; discussion 964-955. https://doi.org/10.1227/NEU.0b013e318208f1da
Funaki T, Takahashi JC, Takagi Y, Kikuchi T, Yoshida K, Mitsuhara T, Kataoka H, Okada T, Fushimi Y, Miyamoto S (2015) Unstable moyamoya disease: clinical features and impact on perioperative ischemic complications. J Neurosurg 122:400–407. https://doi.org/10.3171/2014.10.jns14231
Ge P, Zhang Q, Ye X, Liu X, Deng X, Li H, Wang R, Zhang Y, Zhang D, Zhao J (2017) Long-term outcome after conservative treatment and direct bypass surgery of moyamoya disease at late suzuki stage. World Neurosurg 103:283–290. https://doi.org/10.1016/j.wneu.2017.03.101
Gupta R, Moore JM, Adeeb N, Griessenauer CJ, Patel AS, Chua MH, Thomas AJ, Ogilvy CS (2016) Clinical presentation, progression, and treatment outcomes of moyamoya disease in the elderly. Acta Neurochir 158:2409–2414. https://doi.org/10.1007/s00701-016-2993-z
Guzman R, Lee M, Achrol A, Bell-Stephens T, Kelly M, Do HM, Marks MP, Steinberg GK (2009) Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article. J Neurosurg 111:927–935. https://doi.org/10.3171/2009.4.jns081649
Hayashi T, Shirane R, Fujimura M, Tominaga T (2010) Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion. J Neurosurg Pediatr 6:73–81. https://doi.org/10.3171/2010.4.peds09478
Houkin K, Tominaga T, Miyamoto S, Suzuki N, Kuroda S, Koizumi A (2018) Recommendationsfor the management of moyamoya disease: a statement from research committee on spontaneous occlusion of the circle of willis (moyamoya disease) [2nd Edition]. Surg Cereb Stroke 46:1–24. https://doi.org/10.2335/scs.46.1
Jeon JP, Kim JE, Cho WS, Bang JS, Son YJ, Oh CW (2018) Meta-analysis of the surgical outcomes of symptomatic moyamoya disease in adults. J Neurosurg 128:793–799. https://doi.org/10.3171/2016.11.jns161688
Kanamori F, Araki Y, Yokoyama K, Uda K, Nishihori M, Izumi T, Okamoto S, Wakabayashi T (2020) Brain compression by encephalo-myo-synangiosis is a risk factor for transient neurological deficits after surgical revascularization in pediatric patients with moyamoya disease. World Neurosurg 133:e558–e566. https://doi.org/10.1016/j.wneu.2019.09.093
Kazumata K, Ito M, Tokairin K, Ito Y, Houkin K, Nakayama N, Kuroda S, Ishikawa T, Kamiyama H (2014) The frequency of postoperative stroke in moyamoya disease following combined revascularization: a single-university series and systematic review. J Neurosurg 121:432–440. https://doi.org/10.3171/2014.1.jns13946
Kim HG, Lee SK, Lee JD (2017) Characteristics of infarction after encephaloduroarteriosynangiosis in young patients with moyamoya disease. J Neurosurg Pediatr 19:1–7. https://doi.org/10.3171/2016.7.peds16218
Kim SH, Choi JU, Yang KH, Kim TG, Kim DS (2005) Risk factors for postoperative ischemic complications in patients with moyamoya disease. J Neurosurg 103:433–438. https://doi.org/10.3171/ped.2005.103.5.0433
Kim SK, Cho BK, Phi JH, Lee JY, Chae JH, Kim KJ, Hwang YS, Kim IO, Lee DS, Lee J, Wang KC (2010) Pediatric moyamoya disease: an analysis of 410 consecutive cases. Ann Neurol 68:92–101. https://doi.org/10.1002/ana.21981
Kim SK, Seol HJ, Cho BK, Hwang YS, Lee DS, Wang KC (2004) Moyamoya disease among young patients: its aggressive clinical course and the role of active surgical treatment. Neurosurgery 54:840–844; discussion 844-846. https://doi.org/10.1227/01.neu.0000114140.41509.14
Kim T, Oh CW, Bang JS, Kim JE, Cho WS (2016) Moyamoya disease: treatment and outcomes. J Stroke 18:21–30. https://doi.org/10.5853/jos.2015.01739
Kuroda S, Houkin K (2008) Moyamoya disease: current concepts and future perspectives. Lancet Neurol 7:1056–1066. https://doi.org/10.1016/s1474-4422(08)70240-0
Kuroda S, Houkin K (2012) Bypass surgery for moyamoya disease: concept and essence of sugical techniques. Neurol Med Chir (Tokyo) 52:287–294. https://doi.org/10.2176/nmc.52.287
Liu XJ, Zhang D, Wang S, Zhao YL, Teo M, Wang R, Cao Y, Ye X, Kang S, Zhao JZ (2015) Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China. J Neurosurg 122:392–399. https://doi.org/10.3171/2014.10.jns132369
Miyamoto S, Yoshimoto T, Hashimoto N, Okada Y, Tsuji I, Tominaga T, Nakagawara J, Takahashi JC (2014) Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan adult moyamoya trial. Stroke 45:1415–1421. https://doi.org/10.1161/strokeaha.113.004386
Miyatake S, Miyake N, Touho H, Nishimura-Tadaki A, Kondo Y, Okada I, Tsurusaki Y, Doi H, Sakai H, Saitsu H, Shimojima K, Yamamoto T, Higurashi M, Kawahara N, Kawauchi H, Nagasaka K, Okamoto N, Mori T, Koyano S, Kuroiwa Y, Taguri M, Morita S, Matsubara Y, Kure S, Matsumoto N (2012) Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Neurology 78:803–810. https://doi.org/10.1212/WNL.0b013e318249f71f
Mukerji N, Cook DJ, Steinberg GK (2015) Is local hypoperfusion the reason for transient neurological deficits after STA-MCA bypass for moyamoya disease? J Neurosurg 122:90–94. https://doi.org/10.3171/2014.8.jns132413
Muraoka S, Araki Y, Kondo G, Kurimoto M, Shiba Y, Uda K, Ota S, Okamoto S, Wakabayashi T (2018) Postoperative cerebral infarction risk factors and postoperative management of pediatric patients with moyamoya disease. World Neurosurg 113:e190–e199. https://doi.org/10.1016/j.wneu.2018.01.212
Park W, Ahn JS, Lee HS, Park JC, Kwun BD (2016) Risk factors for newly developed cerebral infarction after surgical revascularization for adults with moyamoya disease. World Neurosurg 92:65–73. https://doi.org/10.1016/j.wneu.2016.03.053
Ravindran K, Wellons JC, Dewan MC (2019) Surgical outcomes for pediatric moyamoya: a systematic review and meta-analysis. J Neurosurg Pediatr 13:1–10. https://doi.org/10.3171/2019.6.peds19241
Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis, Health Labour Sciences Research Grant for Research on Measures for Intractable Diseases (2012) Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). Neurol Med Chir (Tokyo) 52:245–266. https://doi.org/10.2176/nmc.52.245
Suzuki J, Takaku A (1969) Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20:288–299. https://doi.org/10.1001/archneur.1969.00480090076012
Uchino H, Nakayama N, Kazumata K, Kuroda S, Houkin K (2016) Edaravone reduces hyperperfusion-related neurological deficits in adult moyamoya disease: historical control study. Stroke 47:1930–1932. https://doi.org/10.1161/strokeaha.116.013304
Uda K, Araki Y, Muraoka S, Ota S, Wada K, Yokoyama K, Nishihori M, Izumi T, Okamoto S, Wakabayashi T (2018) Intraoperative evaluation of local cerebral hemodynamic change by indocyanine green videoangiography: prediction of incidence and duration of postoperative transient neurological events in patients with moyamoya disease. J Neurosurg 1:1–9. https://doi.org/10.3171/2017.10.jns171523
Wei W, Chen X, Yu J, Li XQ (2019) Risk factors for postoperative stroke in adults patients with moyamoya disease: a systematic review with meta-analysis. BMC Neurol 19:98. https://doi.org/10.1186/s12883-019-1327-1
Williamson RW, Abla AA, Zabramski JM, Nakaji P, Spetzler RF, Wanebo JE (2017) Revascularization of moyamoya angiopathy in older adults. World Neurosurg 99:37–40. https://doi.org/10.1016/j.wneu.2016.11.073
Yu L, Ma L, Huang Z, Shi Z, Wang R, Zhao Y, Zhang D (2019) Revascularization surgery in patients with ischemic-type moyamoya disease: predictors for postoperative stroke and long-term outcomes. World Neurosurg 128:e582–e596. https://doi.org/10.1016/j.wneu.2019.04.214
Zhao M, Deng X, Gao F, Zhang D, Wang S, Zhang Y, Wang R, Zhao J (2017) Ischemic stroke in young adults with moyamoya disease: prognostic factors for stroke recurrence and functional outcome after revascularization. World Neurosurg 103:161–167. https://doi.org/10.1016/j.wneu.2017.03.146
Zhao M, Deng X, Zhang D, Wang S, Zhang Y, Wang R, Zhao J (2018) Risk factors for and outcomes of postoperative complications in adult patients with moyamoya disease. J Neurosurg 1:1–12. https://doi.org/10.3171/2017.10.jns171749
Zheng J, Yu LB, Dai KF, Zhang Y, Wang R, Zhang D (2019) Clinical features, surgical treatment, and long-term outcome of a multicenter cohort of pediatric moyamoya. Front Neurol 10:14. https://doi.org/10.3389/fneur.2019.00014
Funding
This work was funded by a grant from the Japan Society for the Promotion of Science to Yoshio Araki (No. 7118 K08967, https://www.jsps.go.jp).
Author information
Authors and Affiliations
Contributions
All authors read and approved the final manuscript. Conception and design: YA and MK. Data acquisition: YA, KY, KU, FK, YS, and TM. Drafting the article: YA. Statistical analysis: KM, RE, and SM. Critical revision and advice: MN, TI, MS, SO, and TW. Supervision: AN.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Code availability
Not applicable.
Ethics approval
This study has been approved by the Bioethics Review Committee of Nagoya University Hospital (2016-0327).
Consent to participate
The requirement for informed consent for this study was waived because of its study design (complete anonymity).
Consent for publication
Not applicable.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Araki, Y., Yokoyama, K., Uda, K. et al. Postoperative stroke and neurological outcomes in the early phase after revascularization surgeries for moyamoya disease: an age-stratified comparative analysis. Neurosurg Rev 44, 2785–2795 (2021). https://doi.org/10.1007/s10143-020-01459-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10143-020-01459-0